Yet a quiet shift is starting in rehab rooms.
For years, people with autoimmune muscle diseases heard the same message: go slow, avoid strain, protect your muscles at all costs. That careful strategy now faces a serious challenge from new research suggesting that brief, high‑intensity sessions might actually help muscles work better, without stoking inflammation.
When everyday movement feels like lifting concrete
Inflammatory myopathies such as polymyositis and dermatomyositis turn simple actions into uphill battles. Patients describe legs that give way on stairs, arms that tire when washing hair, and a lingering breathlessness after basic chores.
These conditions arise when the immune system mistakenly attacks muscle tissue, causing chronic inflammation. By the time specialists confirm the diagnosis, many patients have already lost around 70% of their normal endurance. Even after a year of immunosuppressive treatment, many never regain the physical capacity they need for normal life.
The roots of that limitation run deep inside the muscle cell. Mitochondria, often described as the muscle’s energy engines, stop working efficiently. They produce less usable energy from the same amount of effort. Standard treatments with corticosteroids and other immune‑modulating drugs can reduce inflammation, yet they also tend to thin muscle, weaken bones and disturb metabolism.
For decades, doctors feared that vigorous exercise would add damage on top of damage, like revving a failing engine. Patients often received advice to stay careful, avoid intense effort and stick to gentle, low‑load moves. That long‑standing belief now faces direct evidence to the contrary.
New data suggest that, when properly supervised, intense exercise does not fuel muscle inflammation in autoimmune disease — it may actually reverse part of the cellular energy failure.
How a Swedish trial flipped the script on “too intense”
A team at the Karolinska Institutet in Sweden recently tested a bolder approach. They recruited 23 adults with recently diagnosed inflammatory myopathies and split them into two groups. One group followed a conventional home‑based programme of moderate exercise. The other trained with high‑intensity interval training (HIIT) three times a week for 12 weeks.
The HIIT protocol looked aggressive on paper. Each session involved six all‑out 30‑second sprints on a stationary bike, separated by two minutes of light pedalling. Heart rate stayed above 85% of each person’s estimated maximum during the intense bursts. Researchers monitored participants closely and adapted workloads to individual capacity.
What changed inside and outside the muscle
After three months, the differences between the groups became clear. People who followed the HIIT programme showed a 16% increase in aerobic capacity, compared with roughly 2% in the moderate‑exercise group. Their time to exhaustion during endurance testing rose by 23%, nearly double the gain seen in participants who stayed with more traditional training.
➡️ Homemade crème caramel: the foolproof trick for a perfect texture and authentic flavour
➡️ This forgotten feature in your car improves visibility during bad weather
➡️ Eclipse of the century: six full minutes of darkness, when it happens and where to watch
➡️ I made this comforting dinner with pantry ingredients and it exceeded expectations
Muscle biopsies added another layer. Samples from the HIIT group showed a marked activation of mitochondrial proteins linked with energy production. Those changes suggest that high‑intensity effort had restarted some of the dormant machinery inside muscle cells.
The striking point for clinicians: performance climbed, cellular energy pathways woke up, and objective signs of inflammation did not flare.
Blood markers of muscle damage stayed stable. Patients did not show clinical signs of worsening disease. They did report muscle soreness and fatigue, as anyone might after tough intervals, but these effects faded and did not push people to dropout.
Safety did not take a back seat
The study design placed guardrails around the intensity. Researchers:
- screened participants medically before including them in the HIIT arm
- used heart‑rate monitoring to keep efforts within agreed limits
- adjusted bike resistance as fitness improved or fatigue increased
- maintained regular check‑ins to catch warning signs early
By treating intensity as a precise dose rather than a vague “go hard” instruction, the team managed to stretch the patients’ capacity without pushing them into danger. That nuanced approach may explain why adherence remained high through the 12‑week protocol.
Why this matters for future treatment plans
The trial arrived at a delicate moment in the management of autoimmune muscle diseases. Drug therapies have improved survival and reduced severe complications, yet many people remain limited by crushing fatigue and weakness. Rehabilitation tends to rely on long, moderate sessions, which often feel exhausting without delivering noticeable improvement.
Short, demanding workouts change that balance. Sessions last minutes rather than an hour, which suits people whose energy evaporates quickly. Gains in aerobic capacity and endurance can make walking to the shops or climbing a flight of stairs less intimidating.
For some patients, high‑intensity intervals may shift the narrative from “protect and preserve” to “train and rebuild”, while still respecting the disease.
Researchers involved in the work also point to another layer: cardiovascular risk. People with chronic inflammatory conditions face higher odds of heart disease and stroke. HIIT, when judged safe for the individual, often improves cardiorespiratory fitness more efficiently than moderate exercise. This added benefit could prove valuable for patients who already juggle multiple medications and comorbidities.
Potential benefits at a glance
| Domain | Potential effect of HIIT |
|---|---|
| Muscle endurance | Higher time to exhaustion during activity |
| Cellular energy | Increased mitochondrial protein activity in biopsies |
| Daily function | Greater ease in walking, climbing, household tasks |
| Cardiovascular health | Improved aerobic capacity, a key factor in heart risk |
| Treatment burden | Shorter sessions, potentially better adherence |
Who might actually benefit — and who should be cautious
Despite the encouraging data, this approach does not suit everyone with muscle inflammation. The Swedish trial involved carefully selected adults in a controlled setting. People with severe heart disease, advanced lung problems or unstable autoimmune activity may face different risks.
Rheumatologists and neurologists suggest that any patient considering such training should first undergo a thorough assessment: cardiac evaluation, current inflammatory markers, muscle strength testing and a clear review of medication side effects. Tailoring comes first, intervals come second.
For some, a stepped approach may work better. A person might start with gentle cycling or walking, then add a few slightly harder intervals, building from there toward something closer to HIIT, if their body tolerates it. The concept of “relative” intensity matters. What counts as hard effort for a fit cyclist differs completely from what challenges a recently diagnosed patient.
Changing the mindset around “rest versus movement”
The study also raises a broader question for chronic disease care. Many conditions, from rheumatoid arthritis to long‑term cancer treatments, bring similar fears around exertion. Patients often learn to associate increased heart rate or muscle burn with danger, because flares have followed exertion in the past.
Carefully supervised training can help rebuild trust in the body. When someone sees that their numbers improve and their symptoms do not spiral, their relationship with movement starts to shift. That psychological effect matters as much as any lab value.
At the same time, health professionals must resist the temptation to turn HIIT into a blanket recommendation. The data set remains small, and most trials come from specialised centres. Outside those walls, differences in supervision, equipment and follow‑up could narrow the safety margin.
What this means for patients right now
For a person living with polymyositis or dermatomyositis, the message is not to jump straight into sprint intervals in the local gym. The takeaway is more subtle: the old rule that “intense exercise equals harm” no longer holds the same weight. Under expert guidance, intensity can become a tool rather than a threat.
A practical path might include three steps: ask your specialist whether you are a candidate for supervised higher‑intensity training, request referral to a physiotherapist or exercise physiologist familiar with inflammatory myopathies, and start with a trial period where symptoms and blood tests are tracked closely.
Researchers now look at longer‑term questions. Can HIIT maintain its benefits over a year or more? Does it allow for lower doses of steroids? Could it delay disability or reduce the need for mobility aids? Those answers will shape whether this method stays a niche option or moves into standard care pathways.
Understanding mitochondrial function in autoimmune muscle disease may also unlock new drug targets. The same proteins that light up in biopsies after intense training could guide therapies aimed at restoring energy production more directly. In that sense, what happens on a bike in a lab might influence the design of future medicines for people whose muscles currently fail them far too early.